LINDSEY HOBSON: Open Payments
NPI 1497990295 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 28 payments from 14 companies in 2025. Trend: 2023 $473 · 2024 $485 · 2025 $838
Food & beverage: $588Consulting: $250
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 6 | $359 |
| AstraZeneca Pharmaceuticals LP | 3 | $84 |
| SCPHARMACEUTICALS INC. | 3 | $69 |
| Kestra Medical Technology Services, Inc. | 3 | $64 |
| Novo Nordisk Inc | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| Chiesi USA, Inc. | 2 | $31 |
| PFIZER INC. | 1 | $28 |
| ABIOMED | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
Products named: EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), SAPIEN 3 Ultra RESILIA, FARXIGA, FUROSCIX, Assure WCD, Ozempic, LEQVIO, CLEVIPREX.
Industry payments across IN — which companies pay providers there.
